22-270
Showing 1 - 25 of 3,614
Extension of Phase 3 Gene Therapy for Painful Diabetic
Completed
- Painful Diabetic Neuropathy
- Diabetic Neuropathy, Painful
- Long-Term Follow-Up of Patients who Received Engensis (VM202)
- Long-Term Follow-Up of Patients who Received Placebo
-
Phoenix, Arizona
- +13 more
Sep 12, 2022
Masseter Muscle Prominence Trial (BOTOX, Placebo for BOTOX)
Not yet recruiting
- Masseter Muscle Prominence
- BOTOX
- Placebo for BOTOX
- (no location specified)
Nov 14, 2023
Survivorship, Prostate Cancer Trial in United States (Acupuncture, Waitlist Control)
Recruiting
- Survivorship
- Prostate Cancer
- Acupuncture
- Waitlist Control
-
Basking Ridge, New Jersey
- +7 more
Sep 9, 2022
Severe Hemophilia A Subjects Who Received BMN 270 inPrior
Enrolling by invitation
- Hemophilia A
-
London, United KingdomRoyal London Hospital, Barts and the London Hemophilia Center
Mar 13, 2023
Hemophilia A Trial in Worldwide (valoctocogene roxaparvovec)
Active, not recruiting
- Hemophilia A
- valoctocogene roxaparvovec
-
Los Angeles, California
- +47 more
Dec 21, 2022
Premenstrual Syndrome Trial in Malatya (Acupresur, Mindfulness, Plasebo)
Active, not recruiting
- Premenstrual Syndrome
- Acupresur
- +2 more
-
Malatya, Centre, TurkeySimge OZTURK
Feb 1, 2023
Respiratory Depression, Cannabis Use, Opioid Use Trial in Leiden (Medicinal cannabis in combination with oxycodon, Medicinal
Recruiting
- Respiratory Depression
- +2 more
- Medicinal cannabis in combination with oxycodon
- Medicinal cannabis in combination with placebo oxycodon
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Feb 10, 2022
Childhood Obesity, Well-Being, Psychological, Physical Inactivity Trial (Food and Nutrition, Physical Activity (FitFirst), Sleep
Not yet recruiting
- Childhood Obesity
- +5 more
- Food and Nutrition
- +3 more
- (no location specified)
Jul 4, 2023
Migraine Disorders, Headache Disorders Trial in Hangzhou (Placebo, 90mg Idebenone, 270mg Idebenone)
Recruiting
- Migraine Disorders
- Headache Disorders
- Placebo
- +2 more
-
Hangzhou, Zhejiang, ChinaKaiming Liu
Jun 12, 2021
Posterior Blepharitis, Meibomian Gland Dysfunction Trial in Carlsbad (AXR-270 Low Dose, AXR-270 High Dose, AXR-270 Vehicle)
Completed
- Posterior Blepharitis
- Meibomian Gland Dysfunction
- AXR-270 Low Dose
- +2 more
-
Carlsbad, CaliforniaAxeroVision, Inc.
Jan 12, 2021
Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density
Active, not recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Inclisiran
- Behavioural Support
-
Sale, Cheshire, United Kingdom
- +16 more
Jan 20, 2023
Multiple Sclerosis Trial in Worldwide (Mavenclad®)
Completed
- Multiple Sclerosis
-
Sydney, New South Wales, Australia
- +53 more
Jul 25, 2022
Risk Stratification in Children With Concussion
Not yet recruiting
- Concussion, Brain
- Mild Traumatic Brain Injury
- (no location specified)
Apr 21, 2023
Population With Hypertension in Primary Care
Recruiting
- Hypertension
- +2 more
- Alcohol biomarker Phosphatidylethanol (PEth)
-
Stockholm, SwedenRegion Stockholm
Oct 18, 2022
Healthy Volunteers Trial in India (TDV, Placebo)
Not yet recruiting
- Healthy Volunteers
- TDV
- Placebo
-
Bhubaneshwar, India
- +7 more
Sep 22, 2023
Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)
Completed
- Periodontitis
- Diabetes Mellitus, Type 2
- Non-Surgical Periodontal Treatment
-
Istanbul, TurkeyMarmara University
Nov 11, 2023
Arthritis, Rheumatoid Trial in Japan (GSK3196165 Dose 1, GSK3196165 Dose 2, GSK3196165 Dose 3)
Completed
- Arthritis, Rheumatoid
- GSK3196165 Dose 1
- +5 more
-
Aichi, Japan
- +31 more
Apr 1, 2019
DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,
Not yet recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- +6 more
- Bridging radiation therapy
- +2 more
- (no location specified)
Jan 4, 2023
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
Androgenetic Alopecia Trial in Edina (incobotulinumtoxin A)
Not yet recruiting
- Androgenetic Alopecia
- incobotulinumtoxin A
- (no location specified)
Jul 7, 2022
Tumor Microenvironment
Active, not recruiting
- Lung Adenocarcinoma
- (no location specified)
Aug 5, 2023
Healthy Male Subjects Trial in Belfast (ENZ215, EU Sourced Prolia, US Sourced Prolia)
Recruiting
- Healthy Male Subjects
- ENZ215
- +2 more
-
Belfast, United KingdomCelerion GB Ltd.
Mar 22, 2022
Fistulizing Crohns Disease, Perianal Crohns Disease Trial in Worldwide (Guselkumab, Placebo)
Recruiting
- Fistulizing Crohns Disease
- Perianal Crohns Disease
- Guselkumab
- Placebo
-
Birmingham, Alabama
- +150 more
Aug 11, 2022